This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Sandbox Reserved 1369

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
 +
{{Sandbox_Reserved_HLSC322}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
 +
==Your Heading Here (maybe something like 'Structure')==
 +
<StructureSection load='1bna' size='340' side='right' caption='Caption for this structure' scene=''>
 +
This is a protein complex formed from Mitogen-Inducible Gene 6 Protein (Mig-6) and Epidermal Growth Factor Receptor (EGFR)4. Mig-6 complexes with and inhibits EGFR. Mig-6 contains a protein domain that can interact with the EGFR protein family4. EGFR catalyzes the phosphorylation of Mig-6 when the two proteins form a complex, and when this occurs, Mig-6 changes its structure and irreversibly inhibits the EGFR4.
-
</scene>{{Sandbox_Reserved_HLSC322}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
+
== Function ==
 +
EGFR plays a role in the metastasization and development of carcinomas, because it contributes to growth in epithelial tissue.The irreversible inhibition EGFR by Mig-6 will, in people with cancer, prevent the cancer from growing and progressing further. Therefore, Mig-6 regulates the activities of EGFR, so that growth does not get out of control.
 +
== Disease ==
 +
The Mig-6/EGFR protein complex has great importance to the prevention and suppression of epithelial tumors. Since EGFR promotes epithelial growth, and therefore the growth of epithelial cancers when they occur, the Mig-6/EGFR complex is essentially a tumor suppressing complex, because Mig-6 inhibits the function of EGFR
 +
== Relevance ==
 +
Mig-6 is a feedback inhibitor that binds, inhibits, and drives internalization of ErbB-family receptors. Mig-6 inactivates the EGFR and thus is critical in better understanding human cancers2.
-
==Description==
+
Somatic mutations in the EGFR kinase domain have been shown to drive lung adenocarcinoma, a specific type of lung cancer. Mig-6 is a target for phosphorylation by mutant EGFR’s and is a promising tumor suppressor for mutant-driven lung adenocarcinoma. During a research study, lung tumor formation progressed faster in mice lacking Mig-62. Interaction between Mig-6 and EGFR, stabilizes EGFR, inhibiting mutant EGFR, and preventing or delaying further growth of mutant EGFR-driven tumors.
-
<StructureSection load='4ZJV' size='340' side='right' caption='Caption for this structure' scene=''>
+
-
This is a protein complex formed from <scene name='77/777689/Crystal_structure_of_egfr_kina/1'>Mitogen-Inducible Gene 6 Protein (Mig-6) and Epidermal Growth Factor Receptor (EGFR)</scene>. Mig-6 complexes with and inhibits EGFR. Mig-6 contains a protein domain that can interact with the EGFR protein family4. EGFR catalyzes the phosphorylation of Mig-6 when the two proteins form a complex, and when this occurs, Mig-6 changes its structure and irreversibly inhibits the EGFR4.
+
 +
Studies have shown that there is a relationship between the deletion of the Mig-6 gene and the formation of certain types of gliomas.5 In addition, deletion of the Mig6-encoding gene in mice has been shown to hyperactivate EGFR signaling, leading to skin hyperplasia, a condition affecting the sebaceous glands, and tumor formation in skin, the lungs and other epithelial tissues.
-
== Function ==
 
- 
-
== Disease ==
 
- 
-
== Relevance ==
 
== Structural highlights ==
== Structural highlights ==
 +
Global Symmetry: Asymmetric - C12
 +
Global Stoichiometry: Hetero 2-mer - AB2
 +
The domain structure of Mig6 includes an N-terminal CRIB domain, a motif that mediates association with the Rho-family GTPase Cdc42 and a C-terminal ErbB-binding region, which is necessary and sufficient for binding and inhibition of EGFR7.
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
</StructureSection>
</StructureSection>
== References ==
== References ==
-
<references/>
+
<2. http://www.rcsb.org/structure/4ZJV
 +
3. https://www.ncbi.nlm.nih.gov/pubmed/25735773
 +
4. https://www.ncbi.nlm.nih.gov/pubmed/16377102
 +
5. https://www.ebi.ac.uk/pdbe/entry/pdb/4zjv/citations>

Revision as of 21:20, 21 February 2018

This Sandbox is Reserved from January through July 31, 2018 for use in the course HLSC322: Principles of Genetics and Genomics taught by Genevieve Houston-Ludlam at the University of Maryland, College Park, USA. This reservation includes Sandbox Reserved 1311 through Sandbox Reserved 1430.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Your Heading Here (maybe something like 'Structure')

Caption for this structure

Drag the structure with the mouse to rotate

References

<2. http://www.rcsb.org/structure/4ZJV 3. https://www.ncbi.nlm.nih.gov/pubmed/25735773 4. https://www.ncbi.nlm.nih.gov/pubmed/16377102 5. https://www.ebi.ac.uk/pdbe/entry/pdb/4zjv/citations>

Personal tools